Clinical Trial Update: Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of BT200 (Rondaptivon Pegol) in patients with Type 2B Von Willebrand disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease Type 2b

Drugs mentioned

• BT200 (Rondaptivon Pegol)

Snippet

Sponsor: Medical University of Vienna | Conditions: Von Willebrand Disease (VWD), Type 2 | Phase 2 | Status: RECRUITING